The peptide succeeded where the steroid failed
GLP-1 for Addiction: the Medical Evidence for Opioid, Nicotine, and Alcohol Use Disorder GLP-1s like Ozempic and Mounjaro have the potential to reach far more patients than existing medications and permanently reduce addiction rates at a society-wide level
A small observational study in 2017 found that intermittent IV infusions of saline dramatically reduced symptoms and improved quality of life in 56 patients suffering from postural tachycardia syndrome (POTS), a disorder that causes a rapid drop in blood volume to the heart upon standing up (4)
It is important to note that B12 injections are not licensed or indicated for weight loss purposes in the UK
According to the study, which will be presented at the American Academy of Neurology Annual Meeting in April 2026, individuals taking GLP-1 drugs were 10% less likely to visit the ER, 14% less likely to be hospitalised, and around 13% less likely to need procedures like nerve blocks or receive triptan prescriptions than those on topiramate
Ozempic (semaglutide) requires a prescription and is only approved for type 2 diabetes